Medicine Description
Tormeel
is a medication used for the treatment of urinary incontinence and overactive bladder. It helps improve the quality of
daily life in patients who experience loss of bladder control or a sudden, frequent urge to urinate.
The medication works by relaxing the muscles of the bladder and reducing involuntary bladder contractions, thereby
helping patients maintain better urinary control throughout the day. Tormeel should be used only after consultation
with a physician to ensure the appropriate dosage is selected for each individual.
Tormeel Ingredients
Tormeel Strengths
-
5
mg film-coated tablets, each pack contains 30 tablets.
10 mg film-coated tablets, each pack contains 10 tablets.
Uses of Tormeel
Treatment of urinary incontinence associated with overactive bladder.
Acts as an antispasmodic for the urinary tract.
Reduces episodes of urinary urgency and frequent urination throughout the day.
Relaxes bladder muscles by acting as a muscarinic receptor antagonist.
Tormeel Dosage
The usual recommended dose is 5 mg once daily, preferably taken at the same time each day to maintain consistent drug
levels.
If symptom control is inadequate, the physician may increase the dose to 10 mg once daily, depending on the patient's
response and tolerability.
The tablet should be swallowed whole with an adequate amount of water without chewing or crushing. It may be taken
with or without food. Patients should follow the prescribed dosage and should not change or discontinue treatment
without consulting their physician.
Tormeel Side Effects
Dry mouth and throat, the most commonly reported adverse effect.
Constipation or mild gastrointestinal disturbances.
Temporary blurred vision or dry eyes.
Mild nausea or indigestion after taking the medication.
Drowsiness or mild headache, particularly during the first few days of treatment.
Contraindications of Tormeel
This medication is contraindicated in patients with acute urinary retention or an inability to empty the bladder. It
should also not be used in individuals with uncontrolled narrow-angle glaucoma.
Its use is also contraindicated in patients with severe hepatic impairment, severe renal impairment, myasthenia
gravis, or known hypersensitivity to solifenacin succinate or any of the other ingredients in the formulation.
Tormeel Alternatives
Vesicare
Soliven
Detrusitol
Urispas
Use During Pregnancy and Breastfeeding
This medication should be used with caution during pregnancy and breastfeeding. Its use during pregnancy is generally
not recommended unless the treating physician determines that the expected therapeutic benefits outweigh the potential
risks, as adequate data regarding its safety during pregnancy are limited.
Women should consult their physician before starting treatment to determine whether therapy is necessary and whether a
more suitable alternative is available.
During breastfeeding, the medication should only be used after medical consultation, as the active ingredient may pass
into breast milk and affect the nursing infant. When appropriate, the physician may recommend alternative medications
or non-pharmacological strategies to help manage symptoms of overactive bladder during pregnancy and lactation.
Storage Conditions
Store in a cool, dry place away from heat and direct sunlight.
Store at a temperature not exceeding 25°C to 30°C.
Keep the container tightly closed and out of the reach of children.
Keep the tablets in their original blister packaging to protect them from moisture.